UK Medicinal Cannabis Company Grow Pharma to Produce Cannabis-Based Medicinal Products for Patients Facing Possible Disruption In Supply

Press release content from Accesswire. The AP news staff was not involved in its creation.
UK Medicinal Cannabis Company Grow Pharma to Produce Cannabis-Based Medicinal Products for Patients Facing Possible Disruption In Supply
February 2, 2021 GMT
LONDON, ENGLAND / ACCESSWIRE / February 2, 2021 / Innovative UK medicinal cannabis distributor Grow Pharma today announced that they have trialled the first UK extraction of a CBMP in a licensed facility, other than GW Pharmaceuticals, in their efforts to replicate and distribute cannabis-based medicinal products (CBMPs) to patients whose supply may be disrupted due to technicalities relating to Brexit.
“Although it has been announced that a temporary solution has been found and companies are working on a longer term solution which may take months, a post Brexit, sustainable and UK based solution for this problem is needed and we are ready to step up to help,” says Pierre van Weperen, CEO of Grow Pharma. He also mentioned that when prescriptions come in, initial samples will be made available free of charge and the actual cost moving forward will be significantly less than parents are used to paying.

Related Keywords

Ireland ,Netherlands ,United Kingdom ,London ,City Of ,Dutch ,Pierre Van Weperen ,Ashok Patel ,Grow Group ,Association Of Pharmaceuticals Unlicensed ,Gw Pharmaceuticals ,Regulatory Agency ,Innovative United Kingdom ,Grow Pharma ,United Kingdom Based ,Grow Trading ,Unlicensed Imports ,Clinical Trials ,Pharmaceuticals Unlicensed ,ஐயர்ல்யாஂட் ,நெதர்லாந்து ,ஒன்றுபட்டது கிஂக்டம் ,லண்டன் ,நகரம் ஆஃப் ,டச்சு ,அசோக் படேல் ,வளர குழு ,சங்கம் ஆஃப் மருந்துகள் உரிமம் பெறாதது ,க்வ் மருந்துகள் ,புதுமையானது ஒன்றுபட்டது கிஂக்டம் ,வளர பார்மா ,ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது ,வளர வர்த்தக ,உரிமம் பெறாதது இறக்குமதி ,மருத்துவ சோதனைகள் ,மருந்துகள் உரிமம் பெறாதது ,